Introducing Marea - a clinical-stage biotech on a mission to leverage large-scale human genetics and adipose biology to revolutionize the treatment of #cardiometabolic diseases. Learn more: businesswire.com/news/home/2024…

Our co-founder & CSO Ethan J. Weiss joined BiotechTV to discuss how we're combining human genetics & adipose biology to develop novel therapies for patients at risk for heart attacks even after controlling classical risk factors. Listen below. ⤵️

Today, we announced the appointment of Ian Clements as our CFO. With his extensive business leadership experience, Dr. Clements will play a key role in advancing our mission to accelerate the next generation of medicines for cardiometabolic diseases. businesswire.com/news/home/2024…

Marea is led by a dynamic team of scientists and company builders with deep knowledge and experience in #cardiometabolic diseases, human genetics, and adipocyte biology. Learn more about the role here: recruiting.paylocity.com/recruiting/job…